BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$288.29
+$0.45(+0.16%)
52
Overall
60
Value
54
Tech
42
Quality
How is this score calculated?
Market Cap
$7.89B
Volume
64.86K
52W Range
$211.43 - $343.12
Target Price
$308.75

Company Overview

Mkt Cap$7.89BPrice$288.29
Volume64.86KChange+0.16%
P/E Ratio10.4Open$287.80
Revenue$2.6BPrev Close$287.84
Net Income$759.9M52W Range$211.43 - $343.12
Div YieldN/ATarget$308.75
Overall52Value60
Quality42Technical54

No chart data available

About Bio-Rad Laboratories Inc. Class A

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Kepler Capital Sticks to Its Buy Rating for BB Biotech (0JYO)

In a report released on April 24, Nicolas Pauillac from Kepler Capital maintained a Buy rating on BB Biotech, with a price target of CHF73.00. The ...

TipRanks Auto-Generated Intelligence Newsdesk2 days ago

Xenetic Biosciences Grants Equity Award to Interim CEO

TipRanks Auto-Generated Newsdesk3 days ago

Bio-Rad Laboratories Stockholders Approve Directors and Governance Items

TipRanks Auto-Generated Newsdesk3 days ago

Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), Elevance Health (ELV) and Regeneron (REGN)

Catie Powers4 days ago

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brian Anderson5 days ago
ABCD
1SymbolPriceChangeVol
2BIO$288.29+0.2%64.86K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.